- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 407/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 407/12
Total number of patents in this class: 1507
10-year publication summary
|
94
|
105
|
110
|
134
|
71
|
107
|
100
|
87
|
72
|
72
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Duk San Neolux Co., Ltd. | 705 |
39 |
| Bristol-myers Squibb Company | 4756 |
38 |
| Merck Patent GmbH | 5772 |
30 |
| LT Materials Co., Ltd. | 443 |
28 |
| Takeda Pharmaceutical Company Limited | 2704 |
25 |
| Boehringer Ingelheim International GmbH | 4490 |
23 |
| LG Chem, Ltd. | 18005 |
20 |
| Samsung Display Co., Ltd. | 39369 |
19 |
| F. Hoffmann-La Roche AG | 7777 |
18 |
| Idemitsu Kosan Co., Ltd. | 4293 |
14 |
| Ono Pharmaceutical Co., Ltd. | 420 |
14 |
| Vertex Pharmaceuticals Incorporated | 1588 |
13 |
| Daiichi Sankyo Company, Limited | 1895 |
13 |
| Syngenta Participations AG | 1472 |
12 |
| BASF SE | 21339 |
11 |
| Janssen Pharmaceutica N.V. | 3125 |
11 |
| Sumitomo Chemical Company, Limited | 8992 |
11 |
| Abbvie Inc. | 1812 |
11 |
| Celgene Corporation | 1405 |
11 |
| Katholieke Universiteit Leuven | 1308 |
11 |
| Other owners | 1135 |